Literature DB >> 4007398

Specificity of antigliadin antibody in celiac disease.

S D Levenson, R K Austin, M D Dietler, D D Kasarda, M F Kagnoff.   

Abstract

Celiac disease is activated in genetically susceptible individuals by the dietary ingestion of wheat gluten and similar proteins in other grains. Gliadins are a complex mixture of proteins that contain at least 40 different components in a single variety of wheat. We have purified the four major electrophoretic fractions of wheat gliadin and examined the specificity of antigliadin antibody for those fractions by radioimmunoassay in 30 patients with celiac disease and 30 matched controls. All patients had been on a gluten-free diet for more than 18 mo and were clinically asymptomatic at the time of study. Seventeen of 30 patients had increased antibody levels to one or more of the gliadin fractions. Twelve of 17 patients had elevated antibody to A or 6D alpha-gliadin, 9 of 17 to beta-gliadin, 10 of 17 to gamma-gliadin, and 8 of 17 to omega-gliadin. Of the 17 subjects, 5 had increased antigliadin antibody levels to one gliadin fraction only, whereas 12 had increased levels to two or more fractions. Of the 17 patients with increased antibody titers, 16 had the G2m(n) immunoglobulin heavy chain allotype marker and 14 had the serologic HLA specificities-B8 or-DR3, or both. Definition of the wheat gliadin fractions and specific gliadin peptides that can activate celiac disease remains an open question. These data indicate that antigliadin antibody in the serum of asymptomatic patients with celiac disease who are maintained on a gluten-free diet can be directed against one or a multiple of gliadin fractions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007398     DOI: 10.1016/0016-5085(85)90737-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  The immunology of coeliac disease.

Authors:  G J Mantzaris; W M Rosenberg; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.

Authors:  M F Kagnoff; Y J Paterson; P J Kumar; D D Kasarda; F R Carbone; D J Unsworth; R K Austin
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

Review 3.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Whipple's disease confined to the CNS presenting with multiple intracerebral mass lesions.

Authors:  S J Wroe; M Pires; B Harding; B D Youl; S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

5.  The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

6.  Familial occurrence of congenital incomplete prepyloric mucosal diaphragm.

Authors:  D B Gahukamble
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

Review 7.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

8.  Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies.

Authors:  A Lerner; V Kumar; T C Iancu
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Variation of serum and intestinal gluten antibody specificities in coeliac disease.

Authors:  J H Skerritt; R B Johnson; P A Hetzel; J T La Brooy; D J Shearman; G P Davidson
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

10.  Immunological analysis of serum for buckwheat fed celiac patients.

Authors:  M L de Francischi; J M Salgado; C P da Costa
Journal:  Plant Foods Hum Nutr       Date:  1994-10       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.